Real-Time Update: Addex Therapeutics Ltd ADR (ADXN) Stock Navigates the Market with Up-to-Date Data

The stock of Addex Therapeutics Ltd ADR (ADXN) has seen a 27.84% increase in the past week, with a 54.20% gain in the past month, and a 161.99% flourish in the past quarter. The volatility ratio for the week is 9.86%, and the volatility levels for the past 30 days are at 7.89% for ADXN. The simple moving average for the past 20 days is 32.74% for ADXN’s stock, with a 70.71% simple moving average for the past 200 days.

Is It Worth Investing in Addex Therapeutics Ltd ADR (NASDAQ: ADXN) Right Now?

Additionally, the 36-month beta value for ADXN is 1.66.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for ADXN is 1.02M and currently, short sellers hold a 1.17% ratio of that float. The average trading volume of ADXN on April 04, 2024 was 9.75K shares.

ADXN) stock’s latest price update

Addex Therapeutics Ltd ADR (NASDAQ: ADXN) has experienced a rise in its stock price by 16.35 compared to its previous closing price of 13.24. However, the company has seen a gain of 27.84% in its stock price over the last five trading days. GlobeNewsWire reported 2024-03-14 that Geneva, Switzerland, March 14, 2024 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer, will present at the Bio-Europe Spring 2024 conference taking place March 18 – 20, 2024 in Barcelona, Spain. Dr. Robert Lütjens, Head of Discovery – Biology, will also be attending this event.

ADXN Trading at 45.15% from the 50-Day Moving Average

After a stumble in the market that brought ADXN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -29.98% of loss for the given period.

Volatility was left at 7.89%, however, over the last 30 days, the volatility rate increased by 9.86%, as shares surge +64.41% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +116.97% upper at present.

During the last 5 trading sessions, ADXN rose by +27.84%, which changed the moving average for the period of 200-days by +14.96% in comparison to the 20-day moving average, which settled at $11.91. In addition, Addex Therapeutics Ltd ADR saw 154.63% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for ADXN

Current profitability levels for the company are sitting at:

  • -5.41 for the present operating margin
  • -7.87 for the gross margin

The net margin for Addex Therapeutics Ltd ADR stands at -5.53. The total capital return value is set at -2.64. Equity return is now at value -198.99, with -128.77 for asset returns.

Based on Addex Therapeutics Ltd ADR (ADXN), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -32.29. The debt to equity ratio resting at 0.08. The interest coverage ratio of the stock is -527.99.

Currently, EBITDA for the company is -20.17 million with net debt to EBITDA at 0.41. When we switch over and look at the enterprise to sales, we see a ratio of 7.15. The receivables turnover for the company is 5.5for trailing twelve months and the total asset turnover is 0.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.97.

Conclusion

In conclusion, Addex Therapeutics Ltd ADR (ADXN) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts